Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inflammation-associated cancer: NF-kappaB is the lynchpin.
Li Q, Withoff S, Verma IM. Li Q, et al. Trends Immunol. 2005 Jun;26(6):318-25. doi: 10.1016/ Trends Immunol. 2005. PMID: 15922948 Review.
NF-kappaB and the regulation of hematopoiesis.
Bottero V, Withoff S, Verma IM. Bottero V, et al. Cell Death Differ. 2006 May;13(5):785-97. doi: 10.1038/sj.cdd.4401888. Cell Death Differ. 2006. PMID: 16528384 Review.
RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alphavbeta3-expressing endothelial cells.
Schraa AJ, Kok RJ, Botter SM, Withoff S, Meijer DK, de Leij LF, Molema G. Schraa AJ, et al. Int J Cancer. 2004 Nov 1;112(2):279-85. doi: 10.1002/ijc.20413. Int J Cancer. 2004. PMID: 15352041
Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis.
Stel AJ, Ten Cate B, Jacobs S, Kok JW, Spierings DC, Dondorff M, Helfrich W, Kluin-Nelemans HC, de Leij LF, Withoff S, Kroesen BJ. Stel AJ, et al. J Immunol. 2007 Feb 15;178(4):2287-95. doi: 10.4049/jimmunol.178.4.2287. J Immunol. 2007. PMID: 17277134
Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.
Versantvoort CH, Withoff S, Broxterman HJ, Kuiper CM, Scheper RJ, Mulder NH, de Vries EG. Versantvoort CH, et al. Int J Cancer. 1995 May 4;61(3):375-80. doi: 10.1002/ijc.2910610317. Int J Cancer. 1995. PMID: 7729950
VP-16-mediated cytotoxicity is modulated by interleukin-3 in a growth factor-dependent leukemic cell line.
Vellenga E, Asschert L, Withoff S, van der Kolk D, de Vries EG. Vellenga E, et al. Leukemia. 1994 Dec;8(12):2060-4. Leukemia. 1994. PMID: 7807995
A growth factor-dependent cell line (TF-1) was treated with interleukin-3 (IL-3) or medium in combination with variable doses of VP-16 to test whether the latter's cytotoxicity can be modulated by IL-3. ...
A growth factor-dependent cell line (TF-1) was treated with interleukin-3 (IL-3) or medium in combination with variable doses of VP-16 to te …
Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.
Withoff S, Keith WN, Knol AJ, Coutts JC, Hoare SF, Mulder NH, de Vries EG. Withoff S, et al. Br J Cancer. 1996 Aug;74(4):502-7. doi: 10.1038/bjc.1996.393. Br J Cancer. 1996. PMID: 8761362 Free PMC article.
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
Withoff S, de Vries EG, Keith WN, Nienhuis EF, van der Graaf WT, Uges DR, Mulder NH. Withoff S, et al. Br J Cancer. 1996 Dec;74(12):1869-76. doi: 10.1038/bjc.1996.647. Br J Cancer. 1996. PMID: 8980384 Free PMC article.
51 results
Jump to page